fluorouracil 2.5g/50ml solution for infusion vials
accord-uk ltd - fluorouracil sodium - solution for infusion - 50mg/1ml
fluorouracil 500mg/10ml solution for injection vials
pfizer ltd - fluorouracil sodium - solution for injection - 50mg/1ml
fluorouracil 1g/20ml solution for injection vials
hospira uk ltd - fluorouracil sodium - solution for injection - 50mg/1ml
fluorouracil 2.5g/50ml solution for infusion vials
pfizer ltd - fluorouracil sodium - solution for infusion - 50mg/1ml
fluorouracil 5g/100ml solution for infusion vials
pfizer ltd - fluorouracil sodium - solution for infusion - 50mg/1ml
fluorouracil "ebewe" 50 mg/ml concentrate for soln for inf
ebewe pharma ges.m.b.h nfg. kg - fluorouracil - concentrate for soln for inf - 50 mg/ml
fluorouracil cream
mylan pharmaceuticals inc. - fluorouracil (unii: u3p01618rt) (fluorouracil - unii:u3p01618rt) - fluorouracil 5 mg in 1 g - fluorouracil 5% topical cream is recommended for the topical treatment of multiple actinic or solar keratoses. in the 5% strength, it is also useful in the treatment of superficial basal cell carcinomas when conventional methods are impractical, such as with multiple lesions or difficult treatment sites. safety and efficacy in other indications have not been established. the diagnosis should be established prior to treatment, since this method has not been proven effective in other types of basal cell carcinomas. with isolated, easily accessible basal cell carcinomas, surgery is preferred since success with such lesions is almost 100%. the success rate with fluorouracil 5% topical cream is approximately 93%, based on 113 lesions in 54 patients. twenty-five lesions treated with the solution produced 1 failure and 88 lesions treated with the cream produced 7 failures. fluorouracil 5% topical cream may cause fetal harm when administered to a pregnant woman. there are no adequate and well-controlled studies in pr
fluorouracil solution
taro pharmaceuticals u.s.a., inc. - fluorouracil (unii: u3p01618rt) (fluorouracil - unii:u3p01618rt) - fluorouracil 20 mg in 1 ml - fluorouracil is recommended for the topical treatment of multiple actinic or solar keratoses. in the 5% strength, it is also useful in the treatment of superficial basal cell carcinomas when conventional methods are impractical, such as with multiple lesions or difficult treatment sites. safety and efficacy in other indications have not been established. the diagnosis should be established prior to treatment, since this method has not been proven effective in other types of basal cell carcinomas. with isolated, easily accessible basal cell carcinomas, surgery is preferred since success with such lesions is almost 100%. the success rate with fluorouracil topical solution is approximately 93%, based on 113 lesions in 54 patients. twenty-five lesions treated with the solution produced 1 failure. fluorouracil may cause fetal harm when administered to a pregnant woman. there are no adequate and well-controlled studies in pregnant women with either the topical or the parenteral forms of fluorouracil. one birth defe
fluorouracil ebewe fluorouracil 1000mg/ 20ml solution for injection vial
sandoz pty ltd - fluorouracil, quantity: 1000 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections - alone or in combination, for the palliative treatment of malignant tumours, particularly of the breast, colon, rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine (cervcial particularly), ovarian and bladder carcinomas. fluorouracil should only be used when other proven measures have failed or are considered impractical.
fluorouracil injection solution
generic medical partners inc - fluorouracil - solution - 250mg - fluorouracil 250mg - antineoplastic agents